Holen Sie sich die Stockscreener-App
188.05
1.79%
3.31
Handel nachbörslich:
188.05
Schlusskurs vom Vortag:
$184.74
Offen:
$183.38
24-Stunden-Volumen:
182.07K
Relative Volume:
0.53
Marktkapitalisierung:
$5.44B
Einnahmen:
$290.51M
Nettoeinkommen (Verlust:
$89.16M
KGV:
62.89
EPS:
2.99
Netto-Cashflow:
$119.18M
1W Leistung:
+2.75%
1M Leistung:
+30.88%
6M Leistung:
+11.33%
1J Leistung:
+4.72%
1-Tages-Spanne:
$181.44
$189.75
1-Wochen-Bereich:
$179.19
$190.01
52-Wochen-Spanne:
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Vergleichen Sie KRYS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
188.05 | 5.35B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Chart based analysis of Krystal Biotech Inc. trendsTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Krystal Biotech Gets US FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 - MarketScreener
FDA grants platform technology designation to Krystal Biotech’s HSV-1 vector - Investing.com India
FDA Grants Platform Technology Status to Krystal Biotech's Gene Therapy - GuruFocus
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis - The Manila Times
FDA Platform Designation: Krystal Biotech's HSV‑1 Viral Vector for KB801 to Advance Neurotrophic Keratitis Treatment - Stock Titan
Is Krystal Biotech Inc. stock a safe buy before earningsMarket Growth Review & Pattern Based Trade Signal System - newser.com
Analyzing Krystal Biotech Inc. with risk reward ratio charts2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Krystal Biotech Inc. stock trend forecast2025 Dividend Review & Weekly Top Performers Watchlists - newser.com
Is Krystal Biotech Inc. meeting your algorithmic filter criteriaWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is Krystal Biotech Inc. stock safe for conservative investors2025 Stock Rankings & Safe Entry Trade Reports - newser.com
What machine learning models say about Krystal Biotech Inc.2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Krystal Biotech (KRYS) Stock Analysis: A 13% Upside Potential Amid Strong Revenue Growth - DirectorsTalk Interviews
What valuation multiples suggest for Krystal Biotech Inc. stock2025 Trade Ideas & Consistent Growth Equity Picks - newser.com
Krystal Biotech Inc. stock outlook for YEARJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Will Krystal Biotech Inc. (4KB) stock outperform Dow Jones2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
Is Krystal Biotech Inc 4KB a good long term investmentCandlestick Trading Patterns & Budget Investment Success - earlytimes.in
I See Some Speculative Wins Starting to Krystal-ize - TheStreet Pro
What high frequency data says about Krystal Biotech Inc.2025 Momentum Check & Fast Gain Stock Tips - newser.com
Published on: 2025-10-10 04:55:37 - newser.com
Market Participants Recognise Krystal Biotech, Inc.'s (NASDAQ:KRYS) Earnings Pushing Shares 29% Higher - simplywall.st
Sentiment analysis tools applied to Krystal Biotech Inc.Trade Exit Report & Technical Entry and Exit Alerts - newser.com
How Krystal Biotech Inc. stock reacts to Fed rate cutsCEO Change & AI Forecasted Entry/Exit Points - newser.com
Is Krystal Biotech Inc. (4KB) stock a buy for dividend portfoliosTrade Performance Summary & Growth Focused Stock Pick Reports - newser.com
How Krystal Biotech Inc. (4KB) stock reacts to monetary easingTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Will Krystal Biotech Inc. (4KB) stock see valuation expansionTrend Reversal & Safe Capital Growth Trade Ideas - newser.com
What’s the recovery path for long term holders of Krystal Biotech Inc.Weekly Trading Summary & Community Verified Trade Signals - newser.com
Is Krystal Biotech Inc. (4KB) stock worth buying before Fed action2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Krystal Biotech Hits Day High with 9.54% Surge in Strong Performance - Markets Mojo
Signal strength of Krystal Biotech Inc. stock in tech scannersJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com
Applying Elliott Wave Theory to Krystal Biotech Inc.Trade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Analyzing drawdowns of Krystal Biotech Inc. with statistical toolsSell Signal & Weekly Return Optimization Alerts - newser.com
Exploring 3 High Growth Tech Stocks in the US Market - Yahoo Finance
Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor? - MSN
Krystal Biotech Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner - Sahm
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):